Walleye Capital’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$548K Buy
+71,592
New +$547K ﹤0.01% 2592
2025
Q4
Sell
-21,055
Closed -$179K 5020
2025
Q3
$88.2K Buy
+21,055
New +$135K ﹤0.01% 3768
2024
Q3
Sell
-49,754
Closed -$448K 5769
2024
Q2
$448K Buy
49,754
+19,503
+64% +$136K ﹤0.01% 3599
2024
Q1
$247K Buy
30,251
+193
+0.6% +$1.58K ﹤0.01% 3822
2023
Q4
$253K Buy
+30,058
New +$348K ﹤0.01% 3502
2023
Q3
Sell
-50,663
Closed -$1.18M 5247
2023
Q2
$1.18M Buy
+50,663
New +$990K ﹤0.01% 1721

Other funds holding REPL

Walleye Capital's REPL Position: Q1 2026 in Review

Walleye Capital opened a new position in Replimune Group (REPL) in Q1 2026: 71,592 shares worth $548K. The stake represents ﹤0.01% of the portfolio and ranks #2592 among its holdings. This is a return to the name: Walleye Capital previously reported a position in REPL as recently as Q3 2025.

Walleye Capital first reported a position in REPL in Q2 2023 and has held it in 6 quarters since. The position peaked at $1.18M in Q2 2023. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Walleye Capital held 71,592 shares of Replimune Group worth $548K as of Q1 2026.
  • Replimune Group was a new Walleye Capital position in Q1 2026.
  • Replimune Group made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2592 holding.
  • Walleye Capital first reported a position in Replimune Group in Q2 2023 and has held it in 6 quarters since.
  • Walleye Capital's Replimune Group position peaked at $1.18M in Q2 2023.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.